Color vision

Wiregrass Museum of Art to Loan EnChroma Glasses to Color Blind Visitors

Retrieved on: 
Wednesday, March 27, 2024

Wiregrass Museum of Art (WMA) and EnChroma® – creators of glasses for color blindness – today announced that WMA will loan EnChroma glasses to visitors who are red-green color blind so they can more fully experience the colors in its exhibits.

Key Points: 
  • Wiregrass Museum of Art (WMA) and EnChroma® – creators of glasses for color blindness – today announced that WMA will loan EnChroma glasses to visitors who are red-green color blind so they can more fully experience the colors in its exhibits.
  • While people with normal color vision see over one million shades of color, the red-green color blind only see an estimated 10% of hues and shades.
  • EnChroma is the lead advocate for “color accessibility,” helping universities, state and national parks, libraries, museums, and other organizations purchase and loan EnChroma glasses to color blind students and guests.
  • They enhance color for approximately 80% of red-green color blind people who have all three of the color cones in their retina functioning properly.

Visual extrasensory | Hypernano hyperspectral MEMS sensor won the White Gold Award of "Visual System Design"

Retrieved on: 
Monday, November 6, 2023

Hypernano is a high-tech enterprise engaged in the R&D, production and sales of hyperspectral MEMS chips, micro modules, and cameras.

Key Points: 
  • Hypernano is a high-tech enterprise engaged in the R&D, production and sales of hyperspectral MEMS chips, micro modules, and cameras.
  • It is the first company in the world to achieve the mass production and engineering and implementation of hyperspectral sensor employing a Fabry-Pérot interferometer(FPI) based on micro-electro-mechnical system(MEMS).
  • As the global leader in hyperspectral imaging technology, Hypernano has brought revolutionary innovations and numerous new application in visual AI.
  • Hypernano has a mission of "4D super perception, everything can be measured", and advanced hyperspectral technology empowers different industries to transform and upgrade.

Radius Delivers Immersive Perimetry at the Speed of Business

Retrieved on: 
Tuesday, April 4, 2023

Radius XR®, the wearable digital healthcare technology brand, has launched its Radius 1.0 software release, challenging the gold standard in perimetric examinations.

Key Points: 
  • Radius XR®, the wearable digital healthcare technology brand, has launched its Radius 1.0 software release, challenging the gold standard in perimetric examinations.
  • Radius is a portable Vision Diagnostic and Patient Engagement system that combines medical-grade diagnostics, business management, and patient education tools in a single wearable device.
  • “Radius 1.0 is designed to achieve that delicate balance between speed and sensitivity without compromising clinical accuracy,” said Khan.
  • Radius 1.0 features RATA®, the Radius Adaptive Testing Algorithm.

Allegro Ophthalmics Receives FDA Agreement Under Special Protocol Assessment (SPA) for Phase 2b/3 Clinical Trial of Risuteganib for the Treatment of Intermediate Dry AMD

Retrieved on: 
Wednesday, April 12, 2023

SAN JUAN CAPISTRANO, Calif., April 12, 2023 /PRNewswire/ -- Allegro Ophthalmics, LLC, a privately held biopharmaceutical company focused on the development of novel mitochondrial stabilizers for the treatment of ocular diseases, today announced that the Company has received agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol Assessment (SPA) for the design of its Phase 2b/3 clinical trial of risuteganib (Luminate®) for the treatment of intermediate, non-exudative age-related macular degeneration (dry AMD).  Finalization of this assessment indicates that the FDA agrees that critical elements of the overall protocol design (e.g., entry criteria, dose selection, endpoints, and planned analyses) are adequate and acceptable for a study intended to support a future marketing application.

Key Points: 
  • The agreement by the FDA of the SPA provides a clear regulatory path for risuteganib for intermediate dry AMD.
  • "We are excited that the overall protocol design of our Phase 2b/3 dry AMD clinical trial was finalized by the FDA," said Vicken Karageozian, M.D., President and CEO of Allegro Ophthalmics, LLC.
  • "The agreement by the FDA of the SPA provides a clear regulatory path for our first-in-class drug, risuteganib, for the treatment of intermediate dry AMD for an unmet medical need.
  • The Phase 2a trial was a prospective, randomized, double masked, placebo-controlled, multi-center U.S. study that evaluated the safety and efficacy of risuteganib in patients with intermediate dry AMD.

OPPO Celebrates 18th Anniversary, Building the Future of Intelligent Living with Inspiration Ahead

Retrieved on: 
Friday, September 16, 2022

The Community has been created to provide an inclusive and open ecosystem for all OPPO users to engage, interact, and share with OPPO and with each other over the long term.

Key Points: 
  • The Community has been created to provide an inclusive and open ecosystem for all OPPO users to engage, interact, and share with OPPO and with each other over the long term.
  • Through the OPPO Global Community, OPPO users and tech enthusiasts will be given more intuitive and convenient access to information and updates about OPPO and OPPO activities, as well a channel for in-depth communications with OPPO technical experts about their experiences with, and insights into, OPPO products and services.
  • Looking to the future with Inspiration Ahead, OPPO will continue to evolve its brand and business to deliver more value for both consumers and society.
  • Beyond devices, OPPO also provides its users with ColorOS operating system and internet services such as OPPO Cloud and OPPO+.

OPPO Brings the OPPO Research Institute Innovation Accelerator to VivaTech 2022

Retrieved on: 
Friday, June 17, 2022

OPPO has joined up with three international startups to share its vision on the future of innovation with technology insiders at VivaTech 2022, as the call for entries for the OPPO Research Institute Innovation Accelerator reaches its closing stages.

Key Points: 
  • OPPO has joined up with three international startups to share its vision on the future of innovation with technology insiders at VivaTech 2022, as the call for entries for the OPPO Research Institute Innovation Accelerator reaches its closing stages.
  • As Europes largest startups and technology event, VivaTech 2022 is also an important stop in the recruitment stage for this years OPPO Research Institute Innovation Accelerator.
  • The OPPO Research Institute Innovation Accelerator was initiated by OPPO to further explore its brand value proposition of Inspiration Ahead.
  • The deadline for submitting a proposal to this years OPPO Research Institute Innovation Accelerator is June 30, 2022.

OPPO celebrates this year's Global Accessibility Awareness Day with collaboration with Blind Mountain Biker Xavier Hopkins

Retrieved on: 
Tuesday, May 24, 2022

SHENZHEN, CHINA - Media OutReach - 19 May 2022 In honor of this year's Global Accessibility Awareness Day, OPPO has teamed up with blind mountain biker Xavier Hopkins to create an Inspiration Matters concept video to show how futurist technologies, which are inspired by of OPPO Air Glass and the AR app CyberReal 2.0 , will empower people to pursue their dreams.

Key Points: 
  • SHENZHEN, CHINA - Media OutReach - 19 May 2022 In honor of this year's Global Accessibility Awareness Day, OPPO has teamed up with blind mountain biker Xavier Hopkins to create an Inspiration Matters concept video to show how futurist technologies, which are inspired by of OPPO Air Glass and the AR app CyberReal 2.0 , will empower people to pursue their dreams.
  • To him, anything further than two meters appears as a great blur, making it difficult for him to accurately perceive distances.
  • I try to memorize whats where because if there are big rocks, I wont be able to see them until Im about to hit them.
  • Therefore, OPPO has implemented several accessibility related services, including the Color Vision Enhancement technology first release on the Find X3 smartphone, which assists users with color vision deficiencies.

OPPO Research Institute Calls for Innovative Proposals on Inclusion and Health with a Total Grant of up to USD $460,000

Retrieved on: 
Wednesday, May 11, 2022

The Innovation Accelerator is being held by the OPPO Research Institute and Microsoft for Startups as a strategic partner.

Key Points: 
  • The Innovation Accelerator is being held by the OPPO Research Institute and Microsoft for Startups as a strategic partner.
  • Centered on the theme of 'Virtuous Innovation', OPPO is looking to recruit proposals under two entry categories Accessible Technology and Digital Health.
  • OPPO brings the aesthetics of technology of global consumers through the ColorOS system Experience, and Internet service like OPPO Cloud and OPPO+.
  • This has included the launch of its flagship OPPO Find X Series and the introduction of the OPPO Reno Series.

OPPO Research Institute Calls for Innovative Proposals on Inclusion and Health with a Total Grant of up to USD $460,000

Retrieved on: 
Wednesday, May 11, 2022

The Innovation Accelerator is being held by the OPPO Research Institute and Microsoft for Startups as a strategic partner.

Key Points: 
  • The Innovation Accelerator is being held by the OPPO Research Institute and Microsoft for Startups as a strategic partner.
  • Centered on the theme of 'Virtuous Innovation', OPPO is looking to recruit proposals under two entry categories Accessible Technology and Digital Health.
  • OPPO brings the aesthetics of technology of global consumers through the ColorOS system Experience, and Internet service like OPPO Cloud and OPPO+.
  • This has included the launch of its flagship OPPO Find X Series and the introduction of the OPPO Reno Series.

DGAP-News: OPPO Research Institute Calls for Innovative Proposals on Inclusion and Health with a Total Grant of up to USD $460,000

Retrieved on: 
Monday, May 9, 2022

The Innovation Accelerator is being held by the OPPO Research Institute and Microsoft for Startups as a strategic partner.

Key Points: 
  • The Innovation Accelerator is being held by the OPPO Research Institute and Microsoft for Startups as a strategic partner.
  • Centered on the theme of Virtuous Innovation, OPPO is looking to recruit proposals under two entry categories Accessible Technology and Digital Health.
  • As we continue to explore new technology, we remain dedicated to doing so in a way that puts people first.
  • Beyond devices, OPPO provides its users with the ColorOS operating system and internet services like OPPO Cloud and OPPO+.